News and Trends 20 Jul 2022
WuXi Biologics to build new center in Singapore as part of $1.4B investment
WuXi Biologics, a global contract research, development and manufacturing organization (CRDMO), has announced a 10-year $1.4 billion investment plan. The plan aims to expand the company’s research, development, and large-scale drug substance and drug product (DS/DP) manufacturing capacity and capabilities in Singapore. The company will build a new site that will add 120,000L biomanufacturing capacity […]
